Tribal Worldwide Spins Off Health Division
Tribal Health aims to bring a digital, data-driven approach to clients including Gilead, GSK and Medela
Tribal Health aims to bring a digital, data-driven approach to clients including Gilead, GSK and Medela
Meghan Rivera reflects on her move to digital therapeutics as well as preparations for the launch of Akili’s first commercial product, a prescription video game approved for use in kids with ADHD.
A deal with Sandoz to lead the global launch of Pear’s two lead products puts marketing muscle behind the nascent class of ‘prescription digital therapeutics.’
The most promising products in pharma’s pipeline will compete in a landscape that increasingly rewards big risks and places an emphasis on novel mechanisms. That comes with a catch.
Teva to cut thousands of U.S. jobs; Regeneron drops Eylea combo drug development; insurers, drugstores, and hospitals increasingly teaming up
GSK hires Google biotech exec to lead R&D; Merck gets FDA-approval for CMV therapy; ex-Lilly exec reportedly top HHS secretary pick
Jim Caggiano had witnessed Provenge’s birth during an earlier turn at Dendreon and couldn’t understand what went wrong.
Sanofi ties price increases to growth rate; Regeneron to target 7,000 docs on new eczema drug Dupixent; NIH and biotech execs meet White House officials
Pharma among top sponsors of Trump inauguration parties; AstraZeneca exec to replace GSK president of global pharmaceuticals; EpiPen rival to relaunch
Here’s a look at 100 experimental therapies in late-stage clinical trials.